DrugPatentWatch Database Preview
Investigational Drug Information for TVB-2640
Email this page to a colleague
What is the drug development status for TVB-2640?
TVB-2640 is an investigational drug.
There have been 9 clinical trials for TVB-2640.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 18th 2021.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Liver Diseases, and Fatty Liver. The leading clinical trial sponsors are Sagimet Biosciences Inc., Ascletis Pharmaceuticals Co., Ltd., and 3V Biosciences, Inc.
There is one US patent protecting this investigational drug and ninety-nine international patents.
Summary for TVB-2640
| US Patents | 1 |
| International Patents | 99 |
| US Patent Applications | 23 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 8 |
| Clinical Trial Progress | Phase 2 (2021-11-18) |
| Vendors | 17 |
Recent Clinical Trials for TVB-2640
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM | Ascletis Pharmaceuticals Co., Ltd. | Phase 3 |
| Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) | Sagimet Biosciences Inc. | Phase 2 |
| Ascending Single-dose Study to Evaluate TVB-2640 in Chinese Healthy Subjects | Ascletis Pharmaceuticals Co., Ltd. | Phase 1 |
Clinical Trial Summary for TVB-2640
Top disease conditions for TVB-2640
Top clinical trial sponsors for TVB-2640
US Patents for TVB-2640
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| TVB-2640 | ⤷ Try it Free | Heterocyclic modulators of lipid synthesis | 3-V Biosciences, Inc. (Menlo Park, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for TVB-2640
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| TVB-2640 | Canada | CA2979696 | 2035-03-19 | ⤷ Try it Free |
| TVB-2640 | China | CN107428728 | 2035-03-19 | ⤷ Try it Free |
| TVB-2640 | European Patent Office | EP3277675 | 2035-03-19 | ⤷ Try it Free |
| TVB-2640 | Japan | JP2018508547 | 2035-03-19 | ⤷ Try it Free |
| TVB-2640 | Japan | JP6758314 | 2035-03-19 | ⤷ Try it Free |
| TVB-2640 | South Korea | KR20170129151 | 2035-03-19 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
